These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16026229)

  • 1. Controversies in primary CNS lymphoma.
    Abrey LE
    Expert Rev Neurother; 2005 Jul; 5(4):459-64. PubMed ID: 16026229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R; Tanaka R
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma.
    Mohile NA; Abrey LE
    Semin Radiat Oncol; 2007 Jul; 17(3):223-9. PubMed ID: 17591569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?].
    Hansen PB; Jensen MK
    Ugeskr Laeger; 2007 Jun; 169(23):2187-9. PubMed ID: 17592682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
    Alnahhas I; Malkin M
    Neurology; 2015 Dec; 85(24):e187-9. PubMed ID: 26668244
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
    Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
    Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral hemorrhage as a late complication after CNS treatment of childhood lymphoma.
    Claviez A; Neubauer B; Link J; Schneppenheim R
    Klin Padiatr; 1998; 210(6):406-8. PubMed ID: 9871896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary central nervous system lymphoma--a single center experience].
    Mitrović Z; Radman I; Aurer I; Petranović D; Santek F; Labar B
    Lijec Vjesn; 2007 Dec; 129(12):391-5. PubMed ID: 18383741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
    Mazhar D; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
    Korfel A; Thiel E
    Leuk Lymphoma; 1998 Aug; 30(5-6):609-17. PubMed ID: 9711923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
    Siepmann K; Rohrbach JM; Duncker G; Zierhut M
    Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.
    Schulz H; Pels H; Schmidt-Wolf I; Zeelen U; Germing U; Engert A
    Haematologica; 2004 Jun; 89(6):753-4. PubMed ID: 15194546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
    Thomas X; Pavan L; Le QH
    Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
    Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
    J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
    Reni M; Mazza E; Foppoli M; Ferreri AJ
    Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system lymphoma: curable without toxicity?
    DeAngelis LM
    Cancer J Sci Am; 1996; 2(3):137-9. PubMed ID: 9166513
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematology. Individualized methotrexate dosing in primary CNS lymphoma.
    Abrey LE
    Nat Rev Clin Oncol; 2010 Jun; 7(6):306-7. PubMed ID: 20517339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.